… Patients Who Are Immunocompromised Initial treatment of COVID-19 for nonhospitalized
patients who are immunocompromised is the same as for other patients: standardduration …

… coronavirus disease 2019 (COVID-19), the so-called post-COVID-19, in non-hospitalized
patients … up to 12 months after COVID-19 in non-hospitalized patients and their impact on work …

… Additional study populations were ICU hospitalized severe COVID-19 patients (n = 24)
and (n = 58) COVID-19 negative subjects whose sera were collected between April and June …

… Most PASC research has focused on hospitalized COVID-19 patients with moderate to severe
… There were 303 non-hospitalized individuals with a positive lab-confirmed COVID-19 test …

… to identify non-hospitalized obese adult patients with COVID-19 between 1 January 2022
and 30 June 2023. Propensity score matching was used to match patients receiving NMV-r (…

… or mildly symptomatic patients. The patients in this study did not develop COVID-19
pneumonia or any other complication. The latency time between COVID-19 symptoms and skin …

… Anti-SARS-CoV-2 monoclonal antibodies are mainstay COVID-19 therapeutics. Safety, …
Non-hospitalized adults were randomized 1:1 within 10 days of COVID-19 symptoms to …

… agents for early COVID-19 in nonhospitalized patients. … COVID-19 or COVID-19–compatible
symptoms and an epidemiologic link to a contact with laboratory-confirmed COVID-19. …

… review of 242 hospitalized patients with symptomatic COVID-19 in China found … nonhospitalized
patients in this analysis was similar to previous reports of patients with mild COVID-19 …

… Post COVID-19 Syndrome (PCS) is the … and non-hospitalized COVID-19 survivors. Exercise
was proposed as a rehabilitation measure for PCS and early studies focused on patients post…